OLN vs SRPT · rev $6.54B vs rev $1.90B
Olin Corporation (OLN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
OLN currently screens at market cap $2.62B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the OLN and SRPT stock pages for the full models.
Not investment advice.